Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics is the official journal of ATTD.
Led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems and software for managing patients with diabetes.
This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.
ATTD 2016 Abstracts published in the DTT Journal click here to download (pdf file).
Special Subscription Rates for ATTD Attendees
Save over 85% on your personal online subscription!
Visit the DTT website and enter group code ATTD.